New Genomic Models for Leiomyosarcoma Treatment

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

A Brutally Honest Review of Practical Magic 2 56 min · 18 Sep 2026 · The Spill

NPR News: 09-18-2026 1AM EDT 4 min · 18 Sep 2026 · NPR News Now

1AM ET 09/18/2026 Newscast 3 min · 18 Sep 2026 · Fox News Hourly Update

The Power of the Spirit in Preaching 6 min · 18 Sep 2026 · Things Unseen with Sinclair B. Ferguson

Report any issue

Source

Recorded07 Nov 2024

Publisherfeeds.buzzsprout.com

Handlerec:1648163

Show notes

Josephine K. Dermawan, MD, PhD, a soft tissue pathologist at Cleveland Clinic joins the Cancer Advances podcast to discuss the development of novel genomic risk stratification models for soft tissue and uterine leiomyosarcomas. Given the complexity and variety of sarcomas, accurately identifying subtypes is key to effective treatment. Listen as Dr. Dermawan explains the challenges of risk stratification and how genomic profiling enhances our ability to predict tumor behavior, leading to more precise treatment decisions.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in